Relationship between retinal layer thickness and the visual field in early age-related macular degeneration

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 12, 2012, Pages 7618-7624

  Acton, Jennifer H ^a,c   Theodore Smith, R ^b,c   Hood, Donald C ^b,d   Greenstein, Vivienne C ^b,c  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Departments of Ophthalmology   (United Kingdom)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PERIMETRY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINAL THICKNESS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL FIELD; VISUAL FIELD DEFECT; COMPARATIVE STUDY; FOLLOW UP; METHODOLOGY; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA MACULA DEGENERATION; SEVERITY OF ILLNESS INDEX; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; RETINAL PIGMENT EPITHELIUM; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VISUAL FIELDS;

EID: 84872197721     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10361     Document Type: Article

References (45)

1. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004; 82:844-851.
2. Rein DB, Wittenborn JS, Zhang X, Honeycutt AA, Lesesne SB, Saaddine J. Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments. Arch Ophthalmol. 2009;127:533-540.
3. Ehrlich R, Mawer NP, Mody CH, Brand CS, Squirrell D. Visual function following photodynamic therapy for central serous retinopathy: a comparison of automated macular microper-imery versus best corrected visual acuity. Clin Exp Ophthal-mol. 2012;40:e32-e39.
4. Finger RP, Charbel Issa P, Hendig D, Scholl HP, Holz FG. Monthly ranibizumab for choroidal neovascularizations secondary to angioid streaks in pseudoxanthoma elasticum: a one-year prospective study. Am J Ophthalmol. 2011;152:695-703.
5. Genead MA, McAnany JJ, Fishman GA. Topical dorzolamide for treatment of cystoid macular edema in patients with choroideremia. Retina. 2012;32:826-833.
6. Wang F, Wang W, Yu S, et al. Functional recovery after intravitreal bevacizumab treatments for idiopathic choroidal neovascularization in young adults. Retina. 2012;32:679-686.
7. van Zeeburg EJ, Maaijwee KJ, Missotten TO, Heimann H, van Meurs JC. A free retinal pigment epithelium-choroid graft in patients with exudative age-related macular degeneration: results up to 7 years. Am J Ophthalmol. 2012;153:120-127.
8. Midena E, Vujosevic S, Convento E, Manfre A, Cavarzeran F, Pilotto E. Microperimetry and fundus autofluorescence in patients with early age-related macular degeneration. Br J Ophthalmol. 2007;91:1499-1503.
9. Remky A, Elsner AE. Blue on yellow perimetry with scanning laser ophthalmoscopy in patients with age related macular disease. Br J Ophthalmol. 2005;89:464-469.
10. Takamine Y, Shiraki K, Moriwaki M, Yasunari T, Miki T. Retinal sensitivity measurement over drusen using scanning laser ophthalmoscope microperimetry. Graefes Arch Clin Exp Ophthalmol. 1998;236:285-290.
11. Hartmann KI, Bartsch DU, Cheng L, et al. Scanning laser ophthalmoscope imaging stabilized microperimetry in dry age-related macular degeneration. Retina. 2011;31:1323-1331.
12. Sunness JS, Johnson MA, Massof RW, Marcus S. Retinal sensitivity over drusen and nondrusen areas-a study using fundus perimetry. Arch Ophthalmol. 1988;106:1081-1084.
13. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178-1181.
14. Freeman SR, Kozak I, Cheng LY, et al. Optical coherence tomography: raster scanning and manual segmentation in determining drusen volume in age-related macular degeneration. Retina. 2010;30:431-435.
15. Khanifar AA, Koreishi AF, Izatt JA, Toth CA. Drusen ultrastruc-ture imaging with spectral domain optical coherence tomography in age-related macular degeneration. Ophthalmology. 2008;115:1883-1890.
16. Schuman SG, Koreishi AF, Farsiu S, Jung SH, Izatt JA, Toth CA. Photoreceptor layer thinning over drusen in eyes with age-related macular degeneration imaged in vivo with spectral-domain optical coherence tomography. Ophthalmology. 2009; 116:488-496.
17. Landa G, Su E, Garcia PM, Seiple WH, Rosen RB. Inner segment-outer segment junctional layer integrity and corresponding retinal sensitivity in dry and wet forms of age-related macular degeneration. Retina. 2011;31:364-370.
18. Spaide RF, Curcio CA. Anatomical correlates to the bands seen in the outer retina by optical coherence tomography: literature review and model. Retina. 2011;31:1609-1619.
19. Clark ME, McGwin G Jr, Neely D, et al. Association between retinal thickness measured by spectral-domain optical coherence tomography (OCT) and rod-mediated dark adaptation in non-exudative age-related maculopathy. Br J Ophthalmol. 2011;95:1427-1432.
20. Pappuru RR, Ouyang Y, Nittala MG, et al. Relationship between outer retinal thickness substructures and visual acuity in eyes with dry age related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52:6743-6748.
21. Curcio CA, Medeiros NE, Millican CL. Photoreceptor loss in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1996;37:1236-1249.
22. Dunaief JL, Dentchev T, Ying GS, Milam AH. The role of apoptosis in age-related macular degeneration. Arch Ophthal-mol. 2002;120:1435-1442.
23. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res. 2001;20: 705-732.
24. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol. 1995;39: 367-374.
25. van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, de Jong PT. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. Arch Ophthalmol. 2003;121:519-526.
26. Chylack LT Jr, Wolfe JK, Singer DM, et al. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol. 1993;111:831-836.
27. Durand AC, Gould GM. A method of determining ocular dominance. J Am Med Assoc. 1910;55:369-370.
28. Hood DC, Lin CE, Lazow MA, Locke KG, Zhang X, Birch DG. Thickness of receptor and post-receptor retinal layers in patients with retinitis pigmentosa measured with frequency-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2009;50:2328-2336.
29. Hood DC, Cho JS, Raza AS, Dale EA, Wang M. Reliability of a computer-aided manual procedure for segmenting optical coherence tomography scans. Optom Vis Sci. 2011;88:113-123.
30. Acton JH, Bartlett NS, Greenstein VC. Comparing the Nidek MP-1 and Humphrey field analyzer in normal subjects. Optom Vis Sci. 2011;88:1288-1297.
31. Heijl A, Lindgren G, Olsson J. A package for the statistical analysis of visual fields. Doc Ophthalmol Proc Ser. 1987;49: 153-168.
32. Owsley C, Jackson GR, Cideciyan AV, et al. Psychophysical evidence for rod vulnerability in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2000;41:267-273.
33. Chen C, Wu L, Wu D, et al. The local cone and rod system function in early age-related macular degeneration. Doc Ophthalmol. 2004;109:1-8.
34. Johnson PT, Lewis GP, Talaga KC, et al. Drusen-associated degeneration in the retina. Invest Ophthalmol Vis Sci. 2003; 44:4481-4488.
35. Johnson PT, Brown MN, Pulliam BC, Anderson DH, Johnson LV. Synaptic pathology, altered gene expression, and degeneration in photoreceptors impacted by drusen. Invest Ophthal-mol Vis Sci. 2005;46:4788-4795.
36. Sarks S, Cherepanoff S, Killingsworth M, Sarks J. Relationship of basal laminar deposit and membranous debris to the clinical presentation of early age-related macular degeneration. Invest Ophthalmol Vis Sci. 2007;48:968-977.
37. Vogt SD, Curcio CA, Wang L, et al. Retinal pigment epithelial expression of complement regulator CD46 is altered early in the course of geographic atrophy. Exp Eye Res. 2011;93:413-423.
38. Querques L, Querques G, Forte R, Souied EH. Microperimetric correlations of autofluorescence and optical coherence tomography imaging in dry age-related macular degeneration. Am J Ophthalmol. 2012;153:1110-1115.
39. Sallo FB, Rechtman E, Peto T, et al. Functional aspects of drusen regression in age-related macular degeneration. Br J Ophthalmol. 2009;93:1345-1350.
40. Gerth C, Delahunt PB, Alam S, Morse LS, Werner JS. Cone-mediated multifocal electroretinogram in age-related macular degeneration: progression over a long-term follow-up. Arch Ophthalmol. 2006;124:345-352.
41. Phipps JA, Guymer RH, Vingrys AJ. Loss of cone function in age-related maculopathy. Invest Ophthalmol Vis Sci. 2003;44: 2277-2283.
42. Stockman A, Sharpe LT. Into the twilight zone: the complexities of mesopic vision and luminous efficiency. Ophthalmic Physiol Opt. 2006;26:225-239.
43. Latch M, Lennie P. Rod-cone interaction in light adaptation. J Physiol. 1977;269:517-534.
44. Frumkes TE, Sekuler MD, Barris MC, Reiss EH, Chalupa LM. Rod-cone interaction in human scotopic vision. 1. Temporal analysis. Vision Res. 1973;13:1269-1282.
45. Wyszecki G, Stiles WS. Color Science. 2nd ed. New York: Wiley; 2000.